Status:
NOT_YET_RECRUITING
Pilot Study of a New Nerve Grafting Method During Bladder Cancer Surgery to Help Preserve Erections.
Lead Sponsor:
Sir Mortimer B. Davis - Jewish General Hospital
Conditions:
Bladder Cancer Requiring Cystectomy
Erectile Dysfunction Following Radical Prostatectomy
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
This pilot study will evaluate the safety and 1-year erectile function recovery in 10 patients undergoing a novel Nerve Restoring Radical Cystectomy (NR-RC), which includes a genitofemoral nerve graft...
Eligibility Criteria
Inclusion
- Patients undergoing standard of care radical cystectomy for bladder cancer
- Patients must have preoperative erectile function with a baseline IIEF score of ≥17
Exclusion
- Patients with previous pelvic surgery
- Patients with previous pelvic radiotherapy
- Patients aged \< 18 years at diagnosis
- Legally incapable patients
- Patients who are unable to complete questionnaires and have no companion to help complete them
- Patients undergoing a concomitant cancer surgery
- Patients with pre-existing neurologic disease
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2029
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT07140588
Start Date
September 1 2025
End Date
February 1 2029
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.